Andrea Lisziewicz
Keine laufenden Positionen mehr
Profil
Andrea Lisziewicz is Director of Finance and Administration for Genetic Immunity LLC.
She joined Genetic Immunity in 2005 and became Director of Business Administration in September, 2006 and Director of Finance and Administration in June 1, 2007.
Ms. Lisziewicz co-founded L&Mark kft in 1992 and currently serves as General Manager.
She worked with Siemens AG from 1986 to 1992.
Ms. Lisziewicz has 15 years of experience in small technology-oriented business administration.
She received an MS degree in Informatics from the Technical University of Dresden in 1986 and an MBA degree in 2004 from the Technical University of Budapest.
Ehemalige bekannte Positionen von Andrea Lisziewicz
Unternehmen | Position | Ende |
---|---|---|
SIEMENS AG | Corporate Officer/Principal | 01.01.1992 |
Genetic Immunity, Inc.
Genetic Immunity, Inc. Pharmaceuticals: OtherHealth Technology Genetic Immunity LLC develops nanomedicines for immune amplification. It offers an immunetherapy platform technology that includes a plasmid DNA based antigen, a nanomedicine formulation, and a topical administration device that targets antigens to dendritic cells. The company was founded by Julianna Lisziewicz and is headquartered in McLean, VA. | Finanzdirektor/CFO | - |
Ausbildung von Andrea Lisziewicz
Technical University of Berlin | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SIEMENS AG | Producer Manufacturing |
Private Unternehmen | 1 |
---|---|
Genetic Immunity, Inc.
Genetic Immunity, Inc. Pharmaceuticals: OtherHealth Technology Genetic Immunity LLC develops nanomedicines for immune amplification. It offers an immunetherapy platform technology that includes a plasmid DNA based antigen, a nanomedicine formulation, and a topical administration device that targets antigens to dendritic cells. The company was founded by Julianna Lisziewicz and is headquartered in McLean, VA. | Health Technology |